Tags

Type your tag names separated by a space and hit enter

Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate.
Enzyme. 1981; 26(6):281-7.E

Abstract

Aconitase activity and citrate oxidation were determined in mitochondrial preparations from rat ventral prostate. Aconitase activity in prostate mitochondria was approximately 10% of the activity observed in kidney preparations. The prostate aconitase activity was completely inhibited by the addition of 1.0 mmol/l zinc and kidney aconitase was inhibited by approximately 50%. The presence of 1.0 mmol/l zinc also markedly inhibited the formation of isocitrate from cis-aconitate. The reduction of NADP by citrate was markedly inhibited (approx. 95%) by 1.0 mmol/l zinc as compared with a 70 and 40% inhibition of aconitate--and isocitrate--stimulated reduction, respectively. These results indicate that zinc might be a strong inhibitor of aconitase activity with an inhibitory effect on isocitrate dehydrogenase also. The effect of 1.0 mmol/l zinc on citrate oxidation was studied by determining 14CO2 production from 6-14C-citrate. 14CO2 was significantly inhibited by zinc. These results further corroborate the conclusion that citrate accumulation in prostate might be the result of limited citrate oxidation which results from a combination of low aconitase activity and possibly zinc inhibition.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

7308179

Citation

Costello, L C., and R B. Franklin. "Aconitase Activity, Citrate Oxidation, and Zinc Inhibition in Rat Ventral Prostate." Enzyme, vol. 26, no. 6, 1981, pp. 281-7.
Costello LC, Franklin RB. Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme. 1981;26(6):281-7.
Costello, L. C., & Franklin, R. B. (1981). Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme, 26(6), 281-7.
Costello LC, Franklin RB. Aconitase Activity, Citrate Oxidation, and Zinc Inhibition in Rat Ventral Prostate. Enzyme. 1981;26(6):281-7. PubMed PMID: 7308179.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. AU - Costello,L C, AU - Franklin,R B, PY - 1981/1/1/pubmed PY - 1981/1/1/medline PY - 1981/1/1/entrez SP - 281 EP - 7 JF - Enzyme JO - Enzyme VL - 26 IS - 6 N2 - Aconitase activity and citrate oxidation were determined in mitochondrial preparations from rat ventral prostate. Aconitase activity in prostate mitochondria was approximately 10% of the activity observed in kidney preparations. The prostate aconitase activity was completely inhibited by the addition of 1.0 mmol/l zinc and kidney aconitase was inhibited by approximately 50%. The presence of 1.0 mmol/l zinc also markedly inhibited the formation of isocitrate from cis-aconitate. The reduction of NADP by citrate was markedly inhibited (approx. 95%) by 1.0 mmol/l zinc as compared with a 70 and 40% inhibition of aconitate--and isocitrate--stimulated reduction, respectively. These results indicate that zinc might be a strong inhibitor of aconitase activity with an inhibitory effect on isocitrate dehydrogenase also. The effect of 1.0 mmol/l zinc on citrate oxidation was studied by determining 14CO2 production from 6-14C-citrate. 14CO2 was significantly inhibited by zinc. These results further corroborate the conclusion that citrate accumulation in prostate might be the result of limited citrate oxidation which results from a combination of low aconitase activity and possibly zinc inhibition. SN - 0013-9432 UR - https://www.unboundmedicine.com/medline/citation/7308179/Aconitase_activity_citrate_oxidation_and_zinc_inhibition_in_rat_ventral_prostate_ DB - PRIME DP - Unbound Medicine ER -